Security key
09075V102
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Total 13F shares
- 51,766,102
- Total 13F value
- $4,713,883,792
- Share change
- +422,416
- Put/Call ratio
- 120%
- SEC-reported price per share
- $91.06
- Number of holders
- 276
- Value change
- +$16,375,983
- Number of buys
- 111
- Number of sells
- 155
- Shares outstanding
- 253,647,595
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
276
Top holders
10
BNTX full security history
Ownership snapshot
Full 13F holder table
BioNTech SE SEC filings
BioNTech SE company facts
Broader feeds
Ownership snapshot
Top reported holders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Medine GmbH
Disclosed value leader
Medine GmbH
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 18%
13D/G row: Medine GmbH
Showing 1-6 of 15 holder rows.
Quick read
Medine GmbH leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Medine GmbH's linked filing trail.
Comparable ownership
Top 5
Medine GmbH
18%
BAILLIE GIFFORD & CO
3.2%
FMR LLC
3%
Se Flossbach von Storch
1.7%
PRIMECAP MANAGEMENT CO/CA/
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medine GmbH |
13D/G
Prof. Ugur Sahin, M.D.
|
18%
|
$4,386,515,536
42,178,034 shares
|
$0 | 31 Mar 2025 |
| BAILLIE GIFFORD & CO |
13F
Company
|
3.2%
|
$936,735,205
8,220,581 shares
|
— | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
3%
|
$877,583,216
7,701,476 shares
|
— | 31 Dec 2024 |
| Se Flossbach von Storch |
13F
Individual
|
1.7%
|
$502,159,760
4,406,843 shares
|
— | 31 Dec 2024 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
1.7%
|
$489,508,352
4,295,817 shares
|
— | 31 Dec 2024 |
| PFIZER INC |
13F
Company
|
1.4%
|
$416,870,236
3,658,361 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
276
Shares
51,766,102
Rows available
276
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
276
Q1 2025 holders
276
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|